NASDAQ:CTRV
Delisted
ContraVir Pharmaceuticals Inc Stock Insider Trading
$1.23
+0 (+0%)
At Close: May 27, 2022
Date | Action | Amount | Person | Type |
---|---|---|---|---|
Jul 03, 2018 | Buy | 8 625 | Jacob Gary S | Warrants |
Jul 03, 2018 | Buy | 15 | Jacob Gary S | Series C Convertible Preferred Stock |
Jul 03, 2018 | Buy | 8 625 | Cavan John T | Warrants |
Jul 03, 2018 | Buy | 15 | Cavan John T | Series C Convertible Preferred Stock |
Jul 03, 2018 | Buy | 1 725 | Brancaccio John P | Warrants |
Jul 03, 2018 | Buy | 3 | Brancaccio John P | Series C Convertible Preferred Stock |
Jan 03, 2018 | Buy | 101 221 | Cavan John T | Common Stock |
Jan 03, 2018 | Buy | 322 092 | Sapirstein James | Common Stock |
Jan 03, 2018 | Buy | 100 654 | Foster Robert T | Common Stock |
Jul 20, 2017 | Buy | 15 000 | Cavan John T | Stock Options |
Jul 06, 2017 | Buy | 46 726 | Cavan John T | Common Stock |
Jul 06, 2017 | Buy | 141 061 | Sapirstein James | Common Stock |
Jul 06, 2017 | Buy | 44 082 | Foster Robert T | Common Stock |
Jun 20, 2017 | Buy | 20 000 | Cavan John T | Common Stock |
Apr 10, 2017 | Buy | 35 000 | Howson Tamar D | Stock Options |
Mar 06, 2017 | Buy | 313 898 | Sapirstein James | Stock Options |
Mar 03, 2017 | Buy | 313 898 | Sapirstein James | Stock Options |
Dec 14, 2016 | Buy | 45 000 | Howson Tamar D | Stock Options |
Oct 27, 2016 | Sell | 16 666 | Sapirstein James | Stock Options |
Oct 27, 2016 | Buy | 16 666 | Sapirstein James | Common Stock |
Sep 20, 2016 | Buy | 45 000 | Adams Thomas Phd | Stock Options |
Aug 26, 2016 | Buy | 18 688 | Cavan John T | Stock Options |
Aug 17, 2016 | Buy | 0 | Cerrone Gabriel | Common Stock |
Aug 17, 2016 | Buy | 0 | Cerrone Gabriel | Common Stock |
Aug 17, 2016 | Buy | 360 000 | Cerrone Gabriel | Stock Options |
Jul 19, 2016 | Buy | 65 000 | Brancaccio John P | Stock Options |
Jul 19, 2016 | Buy | 65 000 | Jacob Gary S | Stock Options |
Jun 13, 2016 | Buy | 500 000 | Sapirstein James | Stock Options |
Jun 10, 2016 | Buy | 100 000 | Foster Robert T | Stock Options |
Apr 01, 2016 | Buy | 100 000 | Cavan John T | Stock Options |
Feb 18, 2016 | Buy | 10 000 | Sapirstein James | Common Stock |
Nov 30, 2015 | Buy | 500 | Sapirstein James | Common Stock |
Nov 23, 2015 | Buy | 2 500 | Sapirstein James | Common Stock |
Jun 04, 2015 | Buy | 150 000 | Sapirstein James | Stock Options |
Dec 03, 2014 | Buy | 500 000 | Sapirstein James | Stock Options |
Dec 03, 2014 | Buy | 38 759 | Brancaccio John P | Stock Options |
Dec 03, 2014 | Buy | 118 638 | Mcguigan Christopher | Stock Options |
Dec 03, 2014 | Buy | 420 000 | Jacob Gary S | Stock Options |
Apr 03, 2014 | Buy | 15 000 | Brancaccio John P | Stock Options |
Apr 03, 2014 | Buy | 20 000 | Denoyer Bernard | Stock Options |
Mar 19, 2014 | Buy | 1 000 000 | Sapirstein James | Stock Options |
Mar 19, 2014 | Buy | 300 000 | Jacob Gary S | Stock Options |
Mar 12, 2014 | Buy | 16 596 | Mcguigan Christopher | Stock Options |
Mar 12, 2014 | Buy | 21 897 | Brancaccio John P | Stock Options |
Mar 04, 2014 | Buy | 4 393 | Brancaccio John P | Common Stock, par value $0.0001 per share |
Feb 18, 2014 | Buy | 1 030 | Denoyer Bernard | Common Stock, par value $0.0001 per share |
Feb 18, 2014 | Buy | 32 935 | Jacob Gary S | Common Stock, par value $0.0001 per share |
Feb 18, 2014 | Buy | 2 015 | Brancaccio John P | Common Stock, par value $0.0001 per share |
Feb 18, 2014 | Sell | 9 000 000 | Synergy Pharmaceuticals, Inc. | Common Stock, par value $0.0001 per share |